HAP's Latest News

October 14, 2021

FDA Panel OKs Moderna Booster for High-Risk Groups

The U.S. Food and Drug Administration’s (FDA) advisory panel recommended approving a half-dose booster of Moderna’s COVID-19 vaccine for older Americans, health care workers, and other high-risk groups.

October 06, 2021

FDA Panel to Evaluate Moderna, J&J Booster Doses

Next week, the U.S. Food and Drug Administration (FDA) will evaluate the next steps for Moderna and Johnson & Johnson’s COVID-19 booster doses, as well as available research about mixing vaccine brands.